Mounjaro® 2.5mg is a once-weekly, pre-filled injection pen containing tirzepatide, a dual GIP and GLP-1 receptor agonist designed to support weight loss and improve blood sugar control in adults with type 2 diabetes. This starter dose is typically used for the first four weeks of treatment to help the body adjust before progressing to higher doses.